132 related articles for article (PubMed ID: 2415365)
1. Phase I study of fludarabine (2-fluoro-ara-AMP).
Kavanagh JJ; Krakoff IH; Bodey GP
Eur J Cancer Clin Oncol; 1985 Sep; 21(9):1009-11. PubMed ID: 2415365
[TBL] [Abstract][Full Text] [Related]
2. Phase II trial of fludarabine phosphate in advanced renal cell carcinoma: an Illinois Cancer Council Study.
Shevrin DH; Lad TE; Kilton LJ; Cobleigh MA; Blough RR; Weidner LL; Vogelzang NJ
Invest New Drugs; 1989 Jul; 7(2-3):251-3. PubMed ID: 2477345
[TBL] [Abstract][Full Text] [Related]
3. Phase II study of fludarabine phosphate in multiple myeloma. A Southwest Oncology Group study.
Kraut EH; Crowley JJ; Grever MR; Keppen MD; Bonnet JD; Hynes HE; Salmon SE
Invest New Drugs; 1990 May; 8(2):199-200. PubMed ID: 1696569
[TBL] [Abstract][Full Text] [Related]
4. Phase II trial of fludarabine in patients with epithelial ovarian cancer.
Kavanagh JJ; Stringer CA; Copeland LJ; Gershenson DM; Saul P
Cancer Treat Rep; 1986 Mar; 70(3):425-6. PubMed ID: 2420446
[No Abstract] [Full Text] [Related]
5. Fludarabine phosphate. Phase II evaluation in advanced soft-tissue sarcomas.
Pazdur R; Samson MK; Baker LH
Am J Clin Oncol; 1987 Aug; 10(4):341-3. PubMed ID: 2441592
[TBL] [Abstract][Full Text] [Related]
6. Phase II trial of fludarabine phosphate (F-Ara-AMP) in patients with advanced breast cancer.
Mittelman A; Ashikari R; Ahmed T; Savona S; Arnold P; Arlin Z
Cancer Chemother Pharmacol; 1988; 22(1):63-4. PubMed ID: 2456162
[TBL] [Abstract][Full Text] [Related]
7. Phase II trial of fludarabine phosphate (F-Ara-AMP) in patients with advanced head and neck cancer.
Mittelman A; Savona S; Puccio C; Chun H; Ahmed T; Feldman E; Sullivan P; Arnold P; Arlin Z
Invest New Drugs; 1990; 8 Suppl 1():S65-7. PubMed ID: 1696246
[TBL] [Abstract][Full Text] [Related]
8. Activity of fludarabine monophosphate in patients with advanced mycosis fungoides: a Southwest Oncology Group study.
Von Hoff DD; Dahlberg S; Hartstock RJ; Eyre HJ
J Natl Cancer Inst; 1990 Aug; 82(16):1353-5. PubMed ID: 1696322
[No Abstract] [Full Text] [Related]
9. Phase II evaluation of fludarabine in patients with metastatic breast cancer: a Southeastern Cancer Study Group trial.
Carpenter JT; Vogel CL; Wang G; Raney M
Cancer Treat Rep; 1986 Oct; 70(10):1235-6. PubMed ID: 2428493
[No Abstract] [Full Text] [Related]
10. Evaluation of fludarabine phosphate in renal cell carcinoma: a Southwest Oncology Group Study.
Balducci L; Blumenstein B; Von Hoff DD; Davis M; Hynes HE; Bukowski RM; Crawford ED
Cancer Treat Rep; 1987 May; 71(5):543-4. PubMed ID: 2436773
[No Abstract] [Full Text] [Related]
11. Phase I clinical trial of fludarabine phosphate (F-ara-AMP).
Casper ES; Mittelman A; Kelson D; Young CW
Cancer Chemother Pharmacol; 1985; 15(3):233-5. PubMed ID: 2414021
[TBL] [Abstract][Full Text] [Related]
12. Phase II study of fludarabine phosphate in patients with advanced colorectal carcinoma.
Ajani JA; Abbruzzese JL; Faintuch JS; Blackburn R; Levin B; Boman BM
Invest New Drugs; 1988 Apr; 6(1):47-50. PubMed ID: 2457566
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary toxicity associated with fludarabine monophosphate.
Hurst PG; Habib MP; Garewal H; Bluestein M; Paquin M; Greenberg BR
Invest New Drugs; 1987; 5(2):207-10. PubMed ID: 2443463
[TBL] [Abstract][Full Text] [Related]
14. Fludarabine monophosphate: a potentially useful agent in chronic lymphocytic leukemia.
Grever MR; Kopecky KJ; Coltman CA; Files JC; Greenberg BR; Hutton JJ; Talley R; Von Hoff DD; Balcerzak SP
Nouv Rev Fr Hematol (1978); 1988; 30(5-6):457-9. PubMed ID: 2464793
[TBL] [Abstract][Full Text] [Related]
15. Phase II study of fludarabine phosphate (NSC 312887) in patients with advanced cervical cancer. A Southwest Oncology Group study.
Von Hoff DD; Green S; Surwit EA; Hannigan EV; Alberts DS
Am J Clin Oncol; 1990 Oct; 13(5):433-5. PubMed ID: 1699401
[TBL] [Abstract][Full Text] [Related]
16. Phase II study of fludarabine phosphate (NSC-312887) in patients with advanced ovarian cancer. A Southwest Oncology Group Study.
Von Hoff DD; Kronmal R; O'Toole RV; Surwit EA; Hutton JJ; Alberts DS
Am J Clin Oncol; 1988 Apr; 11(2):146-8. PubMed ID: 2451882
[TBL] [Abstract][Full Text] [Related]
17. Phase II study of fludarabine phosphate (NSC-312887) in patients with advanced endometrial cancer. A Southwest Oncology Group Study.
Von Hoff DD; Green S; Alberts DS; Stock-Novack DL; Surwit EA; Miller TP; Stephens RL
Am J Clin Oncol; 1991 Jun; 14(3):193-4. PubMed ID: 1709556
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of fludarabine phosphate in small cell carcinoma. A Southwest Oncology Group Study.
Rainey JM; Hill JB; Crowley J
Invest New Drugs; 1988 Apr; 6(1):45-6. PubMed ID: 2457565
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of fludarabine phosphate in patients with recurrent glioma.
Cascino TL; Brown LD; Morton RF; Everson LK; Marschke RF; Dinapoli RP; O'Fallon JR
Am J Clin Oncol; 1988 Oct; 11(5):586-8. PubMed ID: 2459951
[TBL] [Abstract][Full Text] [Related]
20. Fludarabine phosphate: a synthetic purine antimetabolite with significant activity against lymphoid malignancies.
Chun HG; Leyland-Jones B; Cheson BD
J Clin Oncol; 1991 Jan; 9(1):175-88. PubMed ID: 1702143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
